'Lazarus drug' may have competition in MI
Important reporting about the harmful push to get other opioid overdose formulations more widely available in Michigan. These new formulations/medications
The Tate Chronicles: Dr Jonathan Stoltman, Director at the Opioid Policy Institute
Great to chat with Jim Tate about our opioid addiction privacy work and the role of opioid settlement
